Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 22

1.

Cerebrovascular and cardiovascular variability interactions investigated through conditional joint transfer entropy in subjects prone to postural syncope.

Bari V, De Maria B, Mazzucco CE, Rossato G, Tonon D, Nollo G, Faes L, Porta A.

Physiol Meas. 2017 May;38(5):976-991. doi: 10.1088/1361-6579/aa638c. Epub 2017 Feb 28.

PMID:
28245206
2.

Mechanical ventilatory modes and cardioventilatory phase synchronization in acute respiratory failure patients.

Mazzucco CE, Marchi A, Bari V, De Maria B, Guzzetti S, Raimondi F, Catena E, Ottolina D, Amadio C, Cravero S, Fossali T, Colombo R, Porta A.

Physiol Meas. 2017 May;38(5):895-911. doi: 10.1088/1361-6579/aa56ae. Epub 2017 Jan 4.

PMID:
28052047
3.

High-throughput screening and rapid inhibitor triage using an infectious chimeric Hepatitis C virus.

Wichroski MJ, Fang J, Eggers BJ, Rose RE, Mazzucco CE, Pokornowski KA, Baldick CJ, Anthony MN, Dowling CJ, Barber LE, Leet JE, Beno BR, Gerritz SW, Agler ML, Cockett MI, Tenney DJ.

PLoS One. 2012;7(8):e42609. doi: 10.1371/journal.pone.0042609. Epub 2012 Aug 6.

4.

A novel small molecule inhibitor of hepatitis C virus entry.

Baldick CJ, Wichroski MJ, Pendri A, Walsh AW, Fang J, Mazzucco CE, Pokornowski KA, Rose RE, Eggers BJ, Hsu M, Zhai W, Zhai G, Gerritz SW, Poss MA, Meanwell NA, Cockett MI, Tenney DJ.

PLoS Pathog. 2010 Sep 2;6(9):e1001086. doi: 10.1371/journal.ppat.1001086.

5.

Ultrasensitive genotypic detection of antiviral resistance in hepatitis B virus clinical isolates.

Fang J, Wichroski MJ, Levine SM, Baldick CJ, Mazzucco CE, Walsh AW, Kienzle BK, Rose RE, Pokornowski KA, Colonno RJ, Tenney DJ.

Antimicrob Agents Chemother. 2009 Jul;53(7):2762-72. doi: 10.1128/AAC.00130-09. Epub 2009 May 11.

6.

Comprehensive evaluation of hepatitis B virus reverse transcriptase substitutions associated with entecavir resistance.

Baldick CJ, Tenney DJ, Mazzucco CE, Eggers BJ, Rose RE, Pokornowski KA, Yu CF, Colonno RJ.

Hepatology. 2008 May;47(5):1473-82. doi: 10.1002/hep.22211.

PMID:
18435459
7.

Entecavir for treatment of hepatitis B virus displays no in vitro mitochondrial toxicity or DNA polymerase gamma inhibition.

Mazzucco CE, Hamatake RK, Colonno RJ, Tenney DJ.

Antimicrob Agents Chemother. 2008 Feb;52(2):598-605. Epub 2007 Dec 3.

8.

Two-year assessment of entecavir resistance in Lamivudine-refractory hepatitis B virus patients reveals different clinical outcomes depending on the resistance substitutions present.

Tenney DJ, Rose RE, Baldick CJ, Levine SM, Pokornowski KA, Walsh AW, Fang J, Yu CF, Zhang S, Mazzucco CE, Eggers B, Hsu M, Plym MJ, Poundstone P, Yang J, Colonno RJ.

Antimicrob Agents Chemother. 2007 Mar;51(3):902-11. Epub 2006 Dec 18.

9.

Conserved fungal genes as potential targets for broad-spectrum antifungal drug discovery.

Liu M, Healy MD, Dougherty BA, Esposito KM, Maurice TC, Mazzucco CE, Bruccoleri RE, Davison DB, Frosco M, Barrett JF, Wang YK.

Eukaryot Cell. 2006 Apr;5(4):638-49.

10.

Identification of a broad-spectrum azasordarin with improved pharmacokinetic properties.

Serrano-Wu MH, Laurent DR, Carroll TM, Dodier M, Gao Q, Gill P, Quesnelle C, Marinier A, Mazzucco CE, Regueiro-Ren A, Stickle TM, Wu D, Yang H, Yang Z, Zheng M, Zoeckler ME, Vyas DM, Balasubramanian BN.

Bioorg Med Chem Lett. 2003 Apr 17;13(8):1419-23.

PMID:
12668003
11.

Sordaricin antifungal agents.

Quesnelle CA, Gill P, Dodier M, St Laurent D, Serrano-Wu M, Marinier A, Martel A, Mazzucco CE, Stickle TM, Barrett JF, Vyas DM, Balasubramanian BN.

Bioorg Med Chem Lett. 2003 Feb 10;13(3):519-24.

PMID:
12565963
12.

Core-modified sordaricin derivatives: synthesis and antifungal activity.

Regueiro-Ren A, Carroll TM, Chen Y, Matson JA, Huang S, Mazzucco CE, Stickle TM, Vyas DM, Balasubramanian BN.

Bioorg Med Chem Lett. 2002 Dec 2;12(23):3403-5.

PMID:
12419371
13.

Sordarin oxazepine derivatives as potent antifungal agents.

Serrano-Wu MH, St Laurent DR, Chen Y, Huang S, Lam KR, Matson JA, Mazzucco CE, Stickle TM, Tully TP, Wong HS, Vyas DM, Balasubramanian BN.

Bioorg Med Chem Lett. 2002 Oct 7;12(19):2757-60.

PMID:
12217370
14.

Oxime derivatives of sordaricin as potent antifungal agents.

Serrano-Wu MH, St Laurent DR, Mazzucco CE, Stickle TM, Barrett JF, Vyas DM, Balasubramanian BN.

Bioorg Med Chem Lett. 2002 Mar 25;12(6):943-6.

PMID:
11958999
15.
16.

A highly conserved intraspecies homolog of the Saccharomyces cerevisiae elongation factor-3 encoded by the HEF3 gene.

Maurice TC, Mazzucco CE, Ramanathan CS, Ryan BM, Warr GA, Puziss JW.

Yeast. 1998 Sep 15;14(12):1105-13.

17.
18.

A member of the Hsp70 family of heat-shock proteins is a putative target for the immunosuppressant 15-deoxyspergualin.

Mazzucco CE, Nadler SG.

Ann N Y Acad Sci. 1993 Jun 23;685:202-4. No abstract available.

PMID:
8363224
20.

Interaction of the immunosuppressant deoxyspergualin with a member of the Hsp70 family of heat shock proteins.

Nadler SG, Tepper MA, Schacter B, Mazzucco CE.

Science. 1992 Oct 16;258(5081):484-6.

PMID:
1411548
21.

Oncostatin M up-regulates low density lipoprotein receptors in HepG2 cells by a novel mechanism.

Grove RI, Mazzucco CE, Radka SF, Shoyab M, Kiener PA.

J Biol Chem. 1991 Sep 25;266(27):18194-9.

22.

[14C]methylammonium transport by Frankia sp. strain CpI1.

Mazzucco CE, Benson DR.

J Bacteriol. 1984 Nov;160(2):636-41.

Supplemental Content

Loading ...
Support Center